nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinalukast—CYSLTR1—Endothelins—EDNRB—melanoma	0.0225	0.0225	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—PTK2B—melanoma	0.0218	0.0218	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—GNA11—melanoma	0.0212	0.0212	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—PLCB4—melanoma	0.0199	0.0199	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—GNAQ—melanoma	0.0197	0.0197	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB4—melanoma	0.0178	0.0178	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—F2RL1—melanoma	0.0169	0.0169	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—EDN1—melanoma	0.0153	0.0153	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2RL1—melanoma	0.0151	0.0151	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—KISS1—melanoma	0.0151	0.0151	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—PRKCA—melanoma	0.0143	0.0143	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAP2K2—melanoma	0.014	0.014	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GRM1—melanoma	0.0138	0.0138	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—melanoma	0.0135	0.0135	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—RAC1—melanoma	0.0133	0.0133	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—TAS2R60—melanoma	0.0133	0.0133	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL1—melanoma	0.0132	0.0132	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—F2RL1—melanoma	0.0131	0.0131	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MMP1—melanoma	0.0129	0.0129	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—melanoma	0.0123	0.0123	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR1—melanoma	0.0113	0.0113	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—F2RL1—melanoma	0.0112	0.0112	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—MC1R—melanoma	0.0111	0.0111	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR7—melanoma	0.0107	0.0107	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL1—melanoma	0.01	0.01	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—KISS1—melanoma	0.01	0.01	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAP2K1—melanoma	0.00994	0.00994	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—F2R—melanoma	0.00973	0.00973	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—melanoma	0.00968	0.00968	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—MC1R—melanoma	0.00954	0.00954	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—EDNRB—melanoma	0.00942	0.00942	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR7—melanoma	0.00914	0.00914	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GNA11—melanoma	0.00889	0.00889	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR2—melanoma	0.00884	0.00884	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—melanoma	0.0087	0.0087	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—F2RL1—melanoma	0.00854	0.00854	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—melanoma	0.00842	0.00842	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GNAQ—melanoma	0.00827	0.00827	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—GRM3—melanoma	0.00803	0.00803	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—melanoma	0.00796	0.00796	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—KISS1—melanoma	0.00761	0.00761	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—melanoma	0.00757	0.00757	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—F2R—melanoma	0.00752	0.00752	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—TAS2R60—melanoma	0.00749	0.00749	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—melanoma	0.0074	0.0074	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCR1—melanoma	0.00737	0.00737	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—EDNRB—melanoma	0.00728	0.00728	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—MC1R—melanoma	0.00726	0.00726	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—GRM1—melanoma	0.00696	0.00696	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CCR7—melanoma	0.00696	0.00696	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—TAS2R60—melanoma	0.0068	0.0068	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR4—melanoma	0.00646	0.00646	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—F2R—melanoma	0.00644	0.00644	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—EDN1—melanoma	0.00641	0.00641	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAPK3—melanoma	0.00636	0.00636	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—melanoma	0.00624	0.00624	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAPK1—melanoma	0.00605	0.00605	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCR2—melanoma	0.00577	0.00577	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—melanoma	0.00573	0.00573	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PLCB4—melanoma	0.00568	0.00568	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL1—melanoma	0.00568	0.00568	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—WNT5A—melanoma	0.00559	0.00559	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—melanoma	0.00554	0.00554	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCA—melanoma	0.00537	0.00537	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—melanoma	0.00525	0.00525	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PLCB4—melanoma	0.00515	0.00515	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL1—melanoma	0.00515	0.00515	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—F2R—melanoma	0.0049	0.0049	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—HRAS—melanoma	0.00486	0.00486	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—F2RL1—melanoma	0.00483	0.00483	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—EDNRB—melanoma	0.00475	0.00475	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—DRAP1—melanoma	0.00472	0.00472	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MYO7A—melanoma	0.00472	0.00472	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GRM3—melanoma	0.00454	0.00454	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—F2RL1—melanoma	0.00438	0.00438	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—KISS1—melanoma	0.0043	0.0043	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—AKT1—melanoma	0.00429	0.00429	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.00425	0.00425	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCR4—melanoma	0.00422	0.00422	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCR1—melanoma	0.00417	0.00417	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GRM3—melanoma	0.00412	0.00412	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—MC1R—melanoma	0.0041	0.0041	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TAS2R60—melanoma	0.00402	0.00402	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GRM1—melanoma	0.00393	0.00393	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CCR7—melanoma	0.00393	0.00393	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—KISS1—melanoma	0.00391	0.00391	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCR1—melanoma	0.00378	0.00378	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MC1R—melanoma	0.00373	0.00373	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—melanoma	0.00372	0.00372	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—RHOB—melanoma	0.00358	0.00358	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GRM1—melanoma	0.00357	0.00357	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCR7—melanoma	0.00357	0.00357	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCR2—melanoma	0.00326	0.00326	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—RHOB—melanoma	0.00325	0.00325	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—EDN1—melanoma	0.00323	0.00323	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—RAC2—melanoma	0.00321	0.00321	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL1—melanoma	0.00304	0.00304	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PLCB4—melanoma	0.00304	0.00304	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCR2—melanoma	0.00296	0.00296	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—RAC2—melanoma	0.00291	0.00291	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—WNT5A—melanoma	0.00287	0.00287	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TRRAP—melanoma	0.00286	0.00286	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CUL3—melanoma	0.00286	0.00286	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKR1B10—melanoma	0.00278	0.00278	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—F2R—melanoma	0.00277	0.00277	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—EDNRB—melanoma	0.00268	0.00268	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—F2RL1—melanoma	0.00259	0.00259	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GAB2—melanoma	0.00254	0.00254	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GNA11—melanoma	0.00254	0.00254	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—F2R—melanoma	0.00252	0.00252	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.00249	0.00249	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EDNRB—melanoma	0.00244	0.00244	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GRM3—melanoma	0.00243	0.00243	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCR4—melanoma	0.00238	0.00238	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.00238	0.00238	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GNAQ—melanoma	0.00236	0.00236	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KISS1—melanoma	0.00231	0.00231	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GAB2—melanoma	0.0023	0.0023	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GNA11—melanoma	0.0023	0.0023	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.00229	0.00229	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.00227	0.00227	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.00227	0.00227	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SKI—melanoma	0.00223	0.00223	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCR1—melanoma	0.00223	0.00223	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MC1R—melanoma	0.0022	0.0022	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—PIK3CA—melanoma	0.0022	0.0022	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AKT3—melanoma	0.00217	0.00217	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCR4—melanoma	0.00216	0.00216	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GNAQ—melanoma	0.00214	0.00214	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.00214	0.00214	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCR7—melanoma	0.00211	0.00211	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GRM1—melanoma	0.00211	0.00211	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SUFU—melanoma	0.00206	0.00206	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AKT3—melanoma	0.00198	0.00198	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.00197	0.00197	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—BCL2L11—melanoma	0.00192	0.00192	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RHOB—melanoma	0.00192	0.00192	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HDAC6—melanoma	0.00184	0.00184	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—EDN1—melanoma	0.00183	0.00183	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.00182	0.00182	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CSF2—melanoma	0.00179	0.00179	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCR2—melanoma	0.00175	0.00175	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL8—melanoma	0.00175	0.00175	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.00174	0.00174	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RAC2—melanoma	0.00172	0.00172	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PRKCA—melanoma	0.00171	0.00171	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—WNT5A—melanoma	0.00169	0.00169	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VEGFC—melanoma	0.00169	0.00169	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EDN1—melanoma	0.00166	0.00166	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CSF2—melanoma	0.00162	0.00162	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—RAC1—melanoma	0.00159	0.00159	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PRKCA—melanoma	0.00156	0.00156	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MAP2K2—melanoma	0.00152	0.00152	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—F2R—melanoma	0.00149	0.00149	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—RAC1—melanoma	0.00144	0.00144	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EDNRB—melanoma	0.00144	0.00144	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PTK2B—melanoma	0.0014	0.0014	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GNA11—melanoma	0.00136	0.00136	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GAB2—melanoma	0.00136	0.00136	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FLT1—melanoma	0.00135	0.00135	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CG—melanoma	0.00134	0.00134	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HDAC2—melanoma	0.00128	0.00128	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCR4—melanoma	0.00128	0.00128	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FOXO4—melanoma	0.00128	0.00128	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GNAQ—melanoma	0.00126	0.00126	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CG—melanoma	0.00122	0.00122	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SYK—melanoma	0.00119	0.00119	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CD—melanoma	0.00118	0.00118	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ITGAV—melanoma	0.00117	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NGFR—melanoma	0.00117	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKT3—melanoma	0.00117	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SOCS1—melanoma	0.00108	0.00108	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MAP2K1—melanoma	0.00108	0.00108	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—S100B—melanoma	0.00108	0.00108	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CD—melanoma	0.00107	0.00107	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ERBB4—melanoma	0.00103	0.00103	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CB—melanoma	0.00103	0.00103	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDKN2B—melanoma	0.00102	0.00102	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CD86—melanoma	0.000988	0.000988	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL8—melanoma	0.000988	0.000988	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EDN1—melanoma	0.00098	0.00098	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CSF2—melanoma	0.000958	0.000958	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF1—melanoma	0.000958	0.000958	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—IL2—melanoma	0.000944	0.000944	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—E2F1—melanoma	0.000938	0.000938	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CB—melanoma	0.000933	0.000933	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PDGFRA—melanoma	0.000928	0.000928	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ITGB3—melanoma	0.000919	0.000919	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PRKCA—melanoma	0.000919	0.000919	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SPP1—melanoma	0.000901	0.000901	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAP2K2—melanoma	0.000898	0.000898	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL8—melanoma	0.000897	0.000897	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—IL2—melanoma	0.000857	0.000857	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TERT—melanoma	0.000854	0.000854	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RAC1—melanoma	0.000852	0.000852	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HIF1A—melanoma	0.000817	0.000817	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KDR—melanoma	0.000781	0.000781	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FN1—melanoma	0.000752	0.000752	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOTCH1—melanoma	0.000736	0.000736	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CD80—melanoma	0.000721	0.000721	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KIT—melanoma	0.00072	0.00072	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APC—melanoma	0.00072	0.00072	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CG—melanoma	0.00072	0.00072	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—NRAS—melanoma	0.00072	0.00072	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EGF—melanoma	0.000711	0.000711	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MAPK3—melanoma	0.000689	0.000689	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—BRAF—melanoma	0.000676	0.000676	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IGF1—melanoma	0.000659	0.000659	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MAPK1—melanoma	0.000656	0.000656	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EGFR—melanoma	0.000656	0.000656	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAP2K1—melanoma	0.000637	0.000637	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CD—melanoma	0.000633	0.000633	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CA—melanoma	0.000627	0.000627	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—KRAS—melanoma	0.000619	0.000619	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF2—melanoma	0.000606	0.000606	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CA—melanoma	0.000569	0.000569	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MDM2—melanoma	0.000567	0.000567	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ERBB2—melanoma	0.000559	0.000559	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CB—melanoma	0.000551	0.000551	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL8—melanoma	0.00053	0.00053	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—HRAS—melanoma	0.000526	0.000526	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDKN1B—melanoma	0.000517	0.000517	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AKT1—melanoma	0.000512	0.000512	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CASP3—melanoma	0.000507	0.000507	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL2—melanoma	0.000506	0.000506	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—IL6—melanoma	0.000504	0.000504	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCND1—melanoma	0.000494	0.000494	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CTNNB1—melanoma	0.000489	0.000489	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MMP9—melanoma	0.000479	0.000479	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDKN1A—melanoma	0.000477	0.000477	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PTEN—melanoma	0.000476	0.000476	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NFKB1—melanoma	0.000474	0.000474	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AKT1—melanoma	0.000465	0.000465	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VEGFA—melanoma	0.00043	0.00043	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—STAT3—melanoma	0.000426	0.000426	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NRAS—melanoma	0.000425	0.000425	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAPK3—melanoma	0.000407	0.000407	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MYC—melanoma	0.000396	0.000396	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAPK1—melanoma	0.000387	0.000387	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EGFR—melanoma	0.000387	0.000387	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KRAS—melanoma	0.000366	0.000366	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CA—melanoma	0.000336	0.000336	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TP53—melanoma	0.000325	0.000325	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HRAS—melanoma	0.000311	0.000311	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL6—melanoma	0.000298	0.000298	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKT1—melanoma	0.000275	0.000275	CbGpPWpGaD
